Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials

AIMS/HYPOTHESIS: This study aimed to evaluate the effect of ertugliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, on eGFR and albuminuria (urine albumin/creatinine ratio [UACR]) vs glimepiride or placebo/glimepiride (non-ertugliflozin) over 104 weeks of treatment in participants with ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherney, David Z. I., Heerspink, Hiddo J. L., Frederich, Robert, Maldonado, Mario, Liu, Jie, Pong, Annpey, Xu, Zhi J., Patel, Shrita, Hickman, Anne, Mancuso, James P., Gantz, Ira, Terra, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228910/
https://www.ncbi.nlm.nih.gov/pubmed/32236732
http://dx.doi.org/10.1007/s00125-020-05133-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228910/
https://www.ncbi.nlm.nih.gov/pubmed/32236732
http://dx.doi.org/10.1007/s00125-020-05133-4

Ejemplares similares